Legionella Testing Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Water testing, IVD testing), By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Legionella Testing Market is projected to grow from USD 303.02 million in 2025 to USD 522.63 million by 2031, at a 9.51% CAGR. This market involves analytical processes to detect specific bacterial antigens or genetic material in water systems and clinical specimens. Key drivers include the widespread deterioration of aging water infrastructure, which facilitates biofilm formation and pathogen growth, alongside stringent public health codes mandating frequent environmental screening. The high mortality rate, estimated at 10 percent of diagnosed cases in 2024 according to the Alliance to Prevent Legionnaires' Disease, underscores the critical need for proactive monitoring and accurate detection in susceptible facilities.
Market Driver
The rising incidence of Legionnaires' disease and pneumonia is a primary market driver, with bacterial proliferation exacerbated by warming climates and aging infrastructure, leading health agencies to prioritize rapid outbreak detection. Notable examples include a severe cluster in Albertville, France (September 2025, 50 confirmed cases), and a substantial outbreak in Harlem, New York (August 2025, 114 confirmed cases), compelling increased testing. Concurrently, technological advancements in rapid molecular diagnostic methods, such as polymerase chain reaction (PCR) techniques, are significantly influencing the market. The Legionella Control Association advanced these modern protocols in May 2025 by providing guidance on ISO/TS 16099 standards for PCR-based detection, thereby reducing turnaround times and enhancing water safety validation.
Market Challenge
A major challenge impeding market expansion is the high cost of advanced molecular diagnostic methods compared to conventional culture techniques. Laboratories frequently face budgetary constraints, limiting the adoption of rapid PCR systems and sustaining reliance on slower traditional methods. This financial barrier hinders the implementation of high-speed testing, particularly in regions prioritizing cost efficiency over diagnostic speed, thereby impacting revenue generation from modern automated platforms. Moreover, with 96 percent of Legionnaires' disease cases in 2024 being sporadic and unlinked to known outbreaks, as per the Alliance to Prevent Legionnaires' Disease, the high expense of advanced screening prevents facility managers from implementing necessary frequent monitoring, consequently limiting the addressable market for premium diagnostic solutions and slowing overall industry growth.
Market Trends
The market is witnessing a significant trend towards portable point-of-use testing devices, which decentralize diagnostic capabilities, enabling rapid on-site screening by facility managers and reducing exposure during potential outbreaks. Innovations in lateral flow immunochromatographic assays, exemplified by the Hydrosense PRO rapid testing kit's 100% accuracy for Legionella pneumophila serogroups 1 and 2-15 in a January 2025 study, bolster confidence in these portable formats and encourage more frequent testing. Another key trend is the evolution towards integrated water safety management services, moving beyond simple pathogen detection to comprehensive risk mitigation strategies that bundle diagnostic testing with digital monitoring, chemical treatment, and data analytics, fostering long-term partnerships and delivering tangible operational efficiencies, as shown by Ecolab's $9.1 billion in cumulative customer value reported in May 2025.
Key Market Players
* Abbott Laboratories
* Beckman Coulter, Inc.
* Bio-Rad Laboratories Inc.
* BIOMeRIEUX SA
* Eiken Chemical Co., Ltd
* Hologic Inc.
* Pro-Lab PLC
* QIAGEN N.V.
* F. Hoffmann-La Roche Ltd
* Takara Bio Inc.
* Thermo Fisher Scientific Inc.
Report Scope
In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Legionella Testing Market, By Type
* Water testing
* IVD testing
# Legionella Testing Market, By End Use
* Microbial culture
* Direct fluorescent antibody (DFA) stain
* PCR
* Others
# Legionella Testing Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.
Available Customizations:
Global Legionella Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Legionella Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Water testing, IVD testing)
5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Legionella Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Legionella Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End Use
6.3.2. Canada Legionella Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End Use
6.3.3. Mexico Legionella Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End Use
7. Europe Legionella Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Legionella Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End Use
7.3.2. France Legionella Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End Use
7.3.3. United Kingdom Legionella Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End Use
7.3.4. Italy Legionella Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End Use
7.3.5. Spain Legionella Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End Use
8. Asia Pacific Legionella Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Legionella Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End Use
8.3.2. India Legionella Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End Use
8.3.3. Japan Legionella Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End Use
8.3.4. South Korea Legionella Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End Use
8.3.5. Australia Legionella Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End Use
9. Middle East & Africa Legionella Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End Use
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Legionella Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End Use
9.3.2. UAE Legionella Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End Use
9.3.3. South Africa Legionella Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End Use
10. South America Legionella Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End Use
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Legionella Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End Use
10.3.2. Colombia Legionella Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By End Use
10.3.3. Argentina Legionella Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Legionella Testing Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Beckman Coulter, Inc.
15.3. Bio-Rad Laboratories Inc.
15.4. BIOMeRIEUX SA
15.5. Eiken Chemical Co., Ltd
15.6. Hologic Inc.
15.7. Pro-Lab PLC
15.8. QIAGEN N.V.
15.9. F. Hoffmann-La Roche Ltd
15.10. Takara Bio Inc.
15.11. Thermo Fisher Scientific Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們